We hypothesized that in essential hypertensive patients (EHs), plasma levels of pro-atherogenic adhesion molecules would be increased and related with urine albumin excretion (UAE). Thus, this study was aimed at evaluating biochemical markers of endothelial activation and their relationship with UAE in a group of patients with uncomplicated EH. In basal condition soluble forms of adhesion molecules intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1, as well as 24-h UAE were assayed. One hundred patients with essential hypertension and no diabetes or ultrasonographic evidence of atherosclerosis were included in the study. Seventy normotensive healthy subjects served as controls. EHs were first studied overall, than were divided into two subgroups: those with UAE X20 mcg/min MAUs and those with UAE o20 mcg/min (non-MAUs). ICAM-1 (Po0.001) and VCAM-1 (Po0.0001) plasma concentrations were higher in EHs than in controls. Microalbuminuric EHs had greater levels of adhesion molecules than nonMAUs (ICAM-1 P ¼ 0.04; VCAM-1 P ¼ 0.02, respectively). In EHs UAE was correlated with ICAM-1 (r ¼ 0.29, P ¼ 0.003), and VCAM-1 (r ¼ 0.30, P ¼ 0.002). These associations were confirmed in multiple regression models (P ¼ 0.02 for both ICAM-1 and VCAM-1) including, along with adhesion molecules, age, body mass index and blood pressures. Our findings show that in essential hypertension there is a very early activation of endothelial adhesion molecules favouring atherosclerosis.
Introduction
Endothelial dysfunction is characterized by a shift of the actions of the endothelium toward reduced vasodilatation, a pro-inflammatory state and prothrombotic properties. 1 Intercellular adhesion molecules (ICAM-1) and vascular cell adhesion molecules (VCAM-1) are expressed on the endothelial membrane, and allow the attachment of leucocyte to the endothelium, participating in the initiating event of the atherosclerotic process. 2, 3 With this regard, it has been hypothesized that arterial hypertension could amplify the local atherogenic phenotype of endothelial cells in regions with low shear stress. 4 Endothelial function in essential hypertension has been mainly investigated by measuring the response of forearm blood flow to factors regulating the local release of nitric oxide (NO). 5 Measuring the plasma concentration of substances which are known to be synthesized in the vascular endothelium represents a relevant approach to these functional studies. 1, 6 Several studies reported increased plasma levels of adhesion molecules, Endothelin-1, C-reactive protein (CRP), tumour necrosis factor-alfa, 8-isoprostaglandin-F2-alfa and of von Willebrand factor in essential hypertensive (EH) subjects. [7] [8] [9] In arterial hypertension microalbuminuria (MAU) has been suggested to express a systemic endothelial dysfunction and to correlate with the risk of cardiovascular disease. Even levels of urine albumin excretion (UAE) below the range used to define MAU, have been associated with increased risk of coronary heart disease, 10, 11 and even very low levels of UAE have recently been associated with coronary heart disease. 12 Considering these clinical findings we hypothesized that even in EH patients with no clinical evidence of atherosclerotic lesions plasma levels of pro-atherogenic adhesion molecules would be increased and related with UAE.
Methods
The study protocol was approved by the ethics committee of our Department and was conducted in accordance with the Declaration of Helsinki principles. All subjects gave an informed consent.
One hundred patients with recently diagnosed, never treated uncomplicated EHs, without diabetes mellitus, aged 4075 (range 30-45) years, were enrolled in the study. All patients had neither left ventricular hypertrophy (LVH) nor ultrasonographic evidence of increased carotid intimal-medial thickness (IMT) nor plaques in the main arteries. As controls, we studied 70 healthy normotensive subjects, aged 3974 years, matched for gender distribution and body mass index.
In EHs the severity of hypertension was defined according to the 2003 European Society of Hypertension Guidelines.
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Clinic blood pressure was considered as the average of three consecutive measurements using a mercury sphygmomanometer after the subject had been supine for 5 min.
Secondary and/or complicated forms of hypertension were ruled out by normal clinical examination, urinalysis, serum creatinine, serum and urinary electrolytes, plasma catecholamines, renin activity and renal echography.
Standard 12-lead electrocardiograms (ECGs) and M-mode echocardiography (echocg), guided by twodimensional echocg, were obtained in all patients, to rule-out left ventricular (LV) hypertrophy (defined at the ECG as Sokolow-Lyons criterion 438 mm; or Cornell criterion 42440 mm Â ms; and at the echocardiogram as LV mass index 4125 g/m 2 in male subjects and 4110 g/m 2 in female subjects 13 ). An ultrasound examination of the main arteries (carotid, aorta, renal and femoral) was carried out to exclude patients having intimal-medial thickening (mean of the maximum IMT of the four far walls of the carotid bifurcations and distal common carotid arteries X0.9 mm 13 ) or atherosclerotic plaques (focal echogenic structures encroaching into the lumen with a thickness of 50% of that of the surrounding walls). Patients with abnormal tests were excluded.
On the day of the study, at 0900, with the patients in supine position and after fasting overnight, blood samples were obtained from an indwelling forearm venous catheter to assay soluble forms of adhesion molecules ICAM-1 and VCAM-1.
Furthermore, serum levels of creatinine, cholesterol, triglyceride and fibrinogen were assayed.
Twenty-four-hour urines were used to estimate creatinine clearance and UAE.
ICAM-1 and VCAM-1 were measured by enzymelinked immunosorbent assay (ELISA) using a solidphase specific sandwich ELISA. 1, 14 Adhesion molecules assay (Bender MedSystem Diagnostics GmbH, Vienna, Austria) had a sensitivity of 3.3 and 0.9 ng/ml for ICAM-1 and VCAM-1, respectively. Coefficient of variations (CV) was 4 and 3.1%, respectively.
UAE was analysed by a solid phase enzyme immunoassay (Microalbumin-Elisa, DRG Diagnostics, Marburg, Germany). The sensitivity of this method is 0.5 mcg/ml, and the intra-assay and interassay CV were p3.6 and p2.9%, respectively.
The average of two UAE determinations was considered as the level of MAU in each subject. Hypertensive patients were first studied overall, and divided successively in microalbuminuric (X20 mcg/min) (MAUs) and non-microalbuminuric (o20 mcg/min) (non-MAUs) subjects. Owing to the skewed distribution, UAE was log-transformed before statistical analysis.
Statistical analysis was carried out using the SYSTAT DATA software package, version 5.2, using Student's t-test for unpaired data, and linear regression analysis for correlations. The independent associations between UAE and ICAM-1 and between UAE and VCAM-1 were evaluated by a stepwise multiple regression analysis in which as independent variables were included ICAM-1 and VCAM-1 (separately from each other), systolic and diastolic blood pressures, age and body mass index. 15 Results are given as mean7s.d.
Results
The clinical data of healthy controls and EHs are shown in Table 1 .
UAE was significantly higher in EHs than in controls. ICAM-1 and VCAM-1 were also greater in hypertensive subjects than in controls (Table 2 ).
Microalbuminuric and non-microalbuminuric hypertensives UAE was significantly higher in non-MAUs EHs than in healthy controls (Table 2) . Furthermore, endothelium-derived factors were significantly greater in non-MAU EHs than in controls (Table 2) .
Microalbuminuric patients manifested higher levels of soluble adhesion molecules than nonmicroalbuminurics (Table 2) .
It is noteworthy that both systolic and diastolic blood pressures were similar in the two subgroups (Table 1) .
Functional correlates of biochemical markers of endothelial function in overall hypertensives
Linear regression analyses showed significant correlations of UAE with ICAM-1 (r ¼ 0.29, P ¼ 0.003) and VCAM-1 in the overall group of EHs (r ¼ 0.30, P ¼ 0.002) (Figure 1 ). By contrast, there were no significant correlations of endothelium-derived factors with serum cholesterol (r ¼ 0.16, for both ICAM-1 and VCAM-1), triglyceride, fibrinogen concentrations and blood pressures.
The associations between UAE and ICAM-1 (b ¼ 0.22; P ¼ 0.02) and between UAE and VCAM-1 were confirmed (b ¼ 0.23; P ¼ 0.02) in multiple regression models in which, as independent variables were added the following parameters: ICAM-1 and VCAM-1 (separately from each other), systolic and diastolic blood pressures, age and body mass index.
Discussion
Systemic endothelial dysfunction precedes the clinical evidence of atherosclerosis, 16 and adhesion molecules mediate leucocyte adhesion to the endothelium early in the atherosclerotic process.
In the present study biochemical markers of endothelial activation, ICAM-1 and VCAM-1 were higher in uncomplicated EH patients than in controls. Furthermore, ICAM and VCAM were greater among non-MAU than MAU hypertensive subjects.
This report has two main findings: the first is the correlation of endothelial factors with UAE.
The fact that both ICAM-1 and VCAM-1 participate in the initiating event of atherosclerosis, allowing the attachment of leucocytes to the endothelium, suggests that the strong activation of pro-atherogenic factors in hypertensive patients may be a key element favouring cardiovascular complications. 3 An increasing number of clinical studies aimed at evaluating whether soluble adhesion molecules are linked to atherosclerotic disease and to cardiovascular risk, demonstrated that ICAM-1 and VCAM-1 plasma levels were related to the pathogenesis of stroke, 17 coronary disease and death. [18] [19] [20] Our study evaluated patients with essential hypertension, having neither clinical signs of coronary and atherosclerotic vascular disease nor altered metabolic pattern. Hence, the finding of increased ICAM-1 and VCAM-1 serum concentrations demonstrates an early, pro-atherogenic, endothelial involvement independent of blood pressures and of metabolic condition in essential hypertension.
Although the precise underlying pathophysiologic mechanisms of the association between MAU and unfavourable cardiovascular outcome have not been totally given, it is conceivable that an explanation could be given by the frequent coexistence of MAU with several markers of cardiovascular risk. Indeed, in hypertensives with LVH augmented levels of soluble adhesion molecules and increased carotid artery intima-media thickness, which is considered an early atherosclerotic marker, have been reported. 21 Furthermore, a role of inflammatory processes cannot be ruled out. C -reactive protein is associated with endothelial cell dysfunction and progression of atherosclerosis. 22 We demonstrated recently 9 in EH subjects increasing and significantly different levels of ICAM-1 and VCAM-1 along with increasing CRP, the latter in turn correlating with both adhesion molecules, and with blood pressures. On the contrary, the same correlations had not been seen in the normotensive control group. It is well known that CRP is considered an established marker of cardiovascular risk, 13 and it has previously been reported a relationship between CRP values, increasing categories of blood pressure levels, 23 and risk of developing arterial hypertension. [24] [25] [26] Although there is now strong evidence that serum CRP levels are an independent risk factor for cardiovascular disease, the mechanisms underlying this association are still uncertain.
The second prominent observation deriving from this study is that soluble forms of ICAM-1 and VCAM-1 were significantly greater in the subgroup of non-microalbuminuric hypertensives than in healthy controls.
A very recent study 12 demonstrated that in the general population urinary albumin excretion, below the MAU definition, was associated with increased CHD risk, independently of hypertension. Thus, the Authors hypothesize that MAU emerges later in the atherosclerotic process.
Our findings, showing a pro-atherogenic endothelial activation in the presence of values of UAE currently considered as 'normal' seem to be in line with this finding.
Indeed, another interesting observation arising from our data concerns levels of UAE in nonmicroalbuminuric patients, that were significantly higher than in healthy controls and were associated with increased plasma concentrations of endothelial factors. These data seem to be in keeping with previous results of some cross-sectional and prospective studies [27] [28] [29] supporting the adoption of a lower MAU threshold for detecting cardiovascular risk in hypertensive individuals. Actually, the current threshold originates from studies on type I diabetic nephropathy, and it was faithfully transferred to investigations on cardiovascular risk in hypertensive individuals and in general population.
Considering that MAU is a marker not only for early renal damage but also for systemic vascular dysfunction, it is conceivable that for identifying cardiovascular risk a lower UAE threshold could be more sensitive. In the innovative report by Klausen 12 it has been suggested changing the normal definition of MAU, as very low levels of UAE were associated to cardiovascular risk independently of usual risk factors. This suggestion has successively been corroborated by other authors in normotensive and non-diabetic individuals, 30 and Klausen 31 reported in 2005 that in hypertensive subjects the association between MAU and coronary heart disease and death is present even when MAU values are lower than 5 mcg/min.
Taking into account this suggestion and our results, we agree that it would be conceivable to reduce the threshold of MAU in essential hypertension.
In our opinion the results of the present study confirm the hypothesis that vascular structural changes are related to impaired endothelial function, 32 pointing to an activation of the endothelium favouring atherosclerosis in uncomplicated hypertensive patients.
Whether or not this relationship is responsible for the development of MAU in EHs with normal renal function deserves further investigation. Nevertheless, in all our results indicate that MAU represents a marker of systemic endothelial changes, and could reflect an underlying development of the atherosclerotic process. Actually, the association of UAE with an 'atherosclerotic profile' has been widely demonstrated: the correlation between UAE and intima-media thickness in microalbuminuric hypertensive patients has been reported, 33 and we recently showed that increased pulse wave velocity correlates with the levels of UAE in newly diagnosed hypertensive subjects. 34 Moreover, we have previously demonstrated a correlation of UAE with endotheliumderived basic Fibroblast Growth Factor and with Endothelin-1 in EHs. 11 Studies in diabetic patients demonstrated that soluble ICAM-1 and VCAM-1 were increased in the presence of either MAU or overt diabetic nephropathy, namely a microvascular disease, suggesting an underlying systemic endothelial dysfunction. 35, 36 It is to note that microalbuminuric hypertensive patients had significantly greater plasma levels of both adhesion molecules than non-microalbuminurics, even in the presence of similar blood pressure values.
In conclusion our findings demonstrate that urinary albumin excretion is related to endothelial activation in uncomplicated essential hypertension. They also suggest that activation of the endothelium may occur very early, preceding the development of atherosclerosis.
